is semaglutide new Medicare's $50 weight-loss drug program: Who qualifies and what are the concerns? Wednesday briefing: The study that

10.1038/nm1196-1254 58 ShanY.GaoX.ZhaoK.XuC.LiH.HuY.et al (2023)

However, compounded injections must be measured and injected for each dose, and hence are safer as an in-office procedure

Additionally, patients taking multiple medications should be evaluated for potential drug interactions or additive effects, particularly if they are also taking statins, which have well-established myopathic potential

Specifically, it sought to analyze the psychometric properties, development processes, and gaps within the current landscape of telehealth questionnaires

results vary based on dosage, adherence to lifestyle modifications, and individual metabolic factors

The post cites large randomized trials including STEP and SELECT behind semaglutide, with reported body weight reductions in the 3 to 15 percent range, versus roughly 2 to 4 percent for myo-inositol in PCOS cohorts